Boraz R A
Dental Service, University of Kansas Medical Center, Kansas City 66103.
ASDC J Dent Child. 1989 May-Jun;56(3):225-7.
This disease is characterized by cutaneous eczema (usually beginning on the face), thrombocytopenic purpura, and an increased susceptibility to infection due to an immunologic defect. Oral manifestations include gingival bleeding and palatal petechiae. Hyperplastic gingiva may now be expected as a complication of cyclosporine A therapy.